Steroid Metabolome Analysis in Disorders of Adrenal Steroid Biosynthesis and Metabolism
Open accessThe DOI matches its Crossref record; 198 of the 206 references it cites were found in a registry or an index; 31 of the 258 sources its claims cite were checked for support.
Abstract
Steroid biosynthesis and metabolism are reflected by the serum steroid metabolome and, in even more detail, by the 24-hour urine steroid metabolome, which can provide unique insights into alterations of steroid flow and output indicative of underlying conditions. Mass spectrometry–based steroid metabolome profiling has allowed for the identification of unique multisteroid signatures associated with disorders of steroid biosynthesis and metabolism that can be used for personalized approaches to diagnosis, differential diagnosis, and prognostic prediction. Additionally, steroid metabolome analysis has been used successfully as a discovery tool, for the identification of novel steroidogenic disorders and pathways as well as revealing insights into the pathophysiology of adrenal disease. Increased availability and technological advances in mass spectrometry–based methodologies have refocused attention on steroid metabolome profiling and facilitated the development of high-throughput steroid profiling methods soon to reach clinical practice. Furthermore, steroid metabolomics, the combination of mass spectrometry–based steroid analysis with machine learning–based approaches, has facilitated the development of powerful customized diagnostic approaches. In this review, we provide a comprehensive up-to-date overview of the utility of steroid metabolome analysis for the diagnosis and management of inborn disorders of steroidogenesis and autonomous adrenal steroid excess in the context of adrenal tumors.
Overview
CoChat Summary
TL;DR
This review describes how serum and 24-hour urine steroid metabolome profiling, especially mass spectrometry–based multisteroid analysis, reveals distinct signatures of inborn steroid biosynthesis/metabolism disorders and autonomous adrenal steroid excess. It highlights steroid metabolomics—mass spectrometry plus machine learning—as a diagnostic, discovery, and prognostic tool, with an ACC malignant steroid fingerprint awaiting prospective validation.
Key findings
- The 24-hour urine steroid metabolome measures net steroid output and can reveal underlying enzymatic deficiencies and autonomous adrenal steroid excess; urinary excretion accounts for ∼80% of steroid excretion.
- Inborn errors show characteristic multisteroid signatures: >90% of congenital adrenal hyperplasia cases are caused by CYP21A2 deficiency, and diagnostic ratios can distinguish disorders, e.g., 5PT/PTONE is typically low (<1.5) in CYP21A2 deficiency but high (>35) in HSD3B2 deficiency.
- In adrenal tumors, routine serum biochemistry detects steroid excess in 60% to 70% of adrenocortical carcinoma (ACC) patients, whereas urine GC-MS profiling demonstrates steroid excess in >90%; a machine learning–derived “malignant steroid fingerprint” can differentiate ACC from adrenocortical adenoma with high sensitivity and specificity.
- Primary aldosteronism affects at least 5% of the hypertensive population, and many patients also cosecrete glucocorticoid and 11-oxygenated androgen metabolites (“Connshing syndrome”); adrenal masses are estimated in 5% of the general population, with only 5% of those being cortisol-producing adenomas manifesting as adrenal Cushing syndrome.
Methods
- Narrative review of published literature; no primary data or new patient cohort are presented.
- Synthesizes mass spectrometry–based steroid profiling approaches, including GC-MS for comprehensive urine steroid metabolite profiling and UHPLC-MS/MS for serum/plasma steroids and, more recently, urine steroid metabolites.
- Focuses on steroid metabolomics—combining mass spectrometry–based steroid analysis with machine learning–based data analysis—for diagnosis, differential diagnosis, and prognostic prediction in inborn steroidogenic disorders and autonomous adrenal steroid excess.
Limitations
- The paper states no formal limitations.
- Evident from the text: as a review, it provides no new primary data, and some cited evidence is retrospective or preliminary; the large-scale prospective validation study of the ACC urine steroid metabolomics test has been completed but results are awaited.
- Evident from the text: there is a paucity of published urine steroid profiling data in HSD17B3 deficiency, and no distinct steroid metabolome signature has been identified for other primary aldosteronism–causing mutations, mostly due to rarity of cases.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
23 Valid · 11 Not valid · 120 Not checked · 59 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“The combination of mass spectrometry–based steroid profiling with machine learning–based data analysis has created a powerful discovery tool, steroid metabolomics, highly suited as a diagnostic biomarker approach (1–4).”
§ Steroid Metabolome Analysis in Disorders of Adrenal Steroid Biosynthesis and Metabolism > Abstract
What the sources say
- Supportedcites [1] Arlt W, Biehl M, Taylor AE, Hahner S, Libé R, Hughes BA, Schneider P, Smith DJ, Stiekema H, Krone N, Porfiri E, Opocher G, Bertherat J, Mantero F, Allolio B, Terzolo M, Nightingale P, Shackleton CH, Bertagna X, Fassnacht M, Stewart PM Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors. J Clin Endocrinol Metab. 2011; 96(12): 3775– 3784. 21917861 PMC3232629 source
The Objective describes mass spectrometry-based steroid profiling followed by machine learning analysis as a steroid metabolomic approach. The Discussion calls the combination a highly promising biomarker approach for differentiating adrenal tumors, while noting that prospective validation is needed before routine clinical use. (LLM, conf=0.91)
- Not checked yetcites [2] Biehl M, Schneider P, Smith DJ, Stiekema H, Taylor AE, Hughes BA, Shackleton CHL, Stewart PM, Arlt W Matrix relevance LVQ in steroid metabolomics based classification of adrenal tumors. Available at: www.i6doc.com/en/livre/?GCOI=28001100967420. Accessed 30 April 2019.
- Not checked yetcites [3] Bunte K, Smith DJ, Chappell MJ, Hassan-Smith ZK, Tomlinson JW, Arlt W, Tiňo P Learning pharmacokinetic models for in vivo glucocorticoid activation. J Theor Biol. 2018; 455: 222– 231. 30048717 source
- Not checked yetcites [4] Thomson W, Jabbari S, Taylor AE, Arlt W, Smith DJ Simultaneous parameter estimation and variable selection via the logit-normal continuous analogue of the spike-and-slab prior. J R Soc Interface. 2019; 16(150): 20180572. 30958174 PMC6364637 source
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“P450 oxidoreductase (POR) is the crucial electron donor for microsomal cytochrome P450 (CYP) enzymes, including the steroidogenic enzymes CYP21A2, CYP17A1, and, to a lesser degree, CYP19A1 (11, 12).”
§ Steroid Metabolome Analysis in Disorders of Adrenal Steroid Biosynthesis and Metabolism > Steroid Metabolome Signatures of Inborn Errors of Steroid Biosynthesis and Metabolism > The steroid metabolome in congenital adrenal hyperplasia
What the sources say
- Supportedcites [11] Baranowski ES, Arlt W, Idkowiak J Monogenic disorders of adrenal steroidogenesis. Horm Res Paediatr. 2018; 89(5): 292– 310. 29874650 PMC6067656 source
The “POR Deficiency” passage in the section “Monogenic Disorders Affecting Co-Factor Enzymes of Steroidogenesis” states the claim directly, including the lesser role of CYP19A1. The supplied passage does not specify a page. (LLM, conf=0.95)
- Partly supportedcites [12] Miller WL, Auchus RJ The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr Rev. 2011; 32(1): 81– 151. 21051590 PMC3365799 sourceExperimental — accuracy not yet measured
The “P450 oxidoreductase” section identifies POR as the sole electron-transfer protein for all microsomal P450s, including P450c21, P450c17, and P450aro. It does not establish that POR donates electrons to P450aro (CYP19A1) to a lesser degree; the “P450 oxidoreductase deficiency” section instead describes mutation-specific effects on P450aro activity. Page numbers are unavailable in our copy. (LLM, conf=0.87)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“In contrast to 17,20-lyase deficiency in the context of CYP17A1 deficiency (see “CAH due to CYP21A2 deficiency” above), which always comes with a degree of impairment of CYP17A1 17α-hydroxylase activity, CYB5A deficiency represents “true” isolated 17,20-lyase deficiency (15, 70);”
§ Steroid Metabolome Analysis in Disorders of Adrenal Steroid Biosynthesis and Metabolism > Steroid Metabolome Signatures of Inborn Errors of Steroid Biosynthesis and Metabolism > Inborn disorders of androgen biosynthesis and metabolism
What the sources say
- Supportedcites [15] Idkowiak J, Randell T, Dhir V, Patel P, Shackleton CHL, Taylor NF, Krone N, Arlt W A missense mutation in the human cytochrome b5 gene causes 46,XY disorder of sex development due to true isolated 17,20 lyase deficiency. J Clin Endocrinol Metab. 2012; 97(3): E465– E475. 22170710 PMC3388247 source
The Discussion (page not specified) reports preserved 17α-hydroxylase activity with 17,20-lyase deficiency in the CYB5A-affected family. It contrasts this with previously reported CYP17A1-associated cases, in which 17α-hydroxylase activity was also impaired. (LLM, conf=0.91)
- Not checked yetcites [70] Kok RC, Timmerman MA, Wolffenbuttel KP, Drop SL, de Jong FH Isolated 17,20-lyase deficiency due to the cytochrome b5 mutation W27X. J Clin Endocrinol Metab. 2010; 95(3): 994– 999. 20080843 source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“However, several previous studies did not find clinically significant androgen deficiency in affected patients (74–78).”
§ Steroid Metabolome Analysis in Disorders of Adrenal Steroid Biosynthesis and Metabolism > Steroid Metabolome Signatures of Inborn Errors of Steroid Biosynthesis and Metabolism > Inborn disorders of sulfation and desulfation
What the sources say
- Not checked yetcites [74] Sánchez-Guijo A, Neunzig J, Gerber A, Oji V, Hartmann MF, Schuppe HC, Traupe H, Bernhardt R, Wudy SA Role of steroid sulfatase in steroid homeostasis and characterization of the sulfated steroid pathway: evidence from steroid sulfatase deficiency. Mol Cell Endocrinol. 2016; 437: 142– 153. 27531568 source
- Not checked yetcites [75] Delfino M, Procaccini EM, Illiano GM, Milone A X-linked ichthyosis: relation between cholesterol sulphate, dehydroepiandrosterone sulphate and patient’s age. Br J Dermatol. 1998; 138(4): 655– 657. 9640374 source
- Not checked yetcites [76] Lykkesfeldt G, Bennett P, Lykkesfeldt AE, Micic S, Møller S, Svenstrup B Abnormal androgen and oestrogen metabolism in men with steroid sulphatase deficiency and recessive X-linked ichthyosis. Clin Endocrinol (Oxf). 1985; 23(4): 385– 393. 3864567 source
- Partly supportedcites [77] Idkowiak J, Taylor AE, Subtil S, O’Neil DM, Vijzelaar R, Dias RP, Amin R, Barrett TG, Shackleton CHL, Kirk JM, Moss C, Arlt W Steroid sulfatase deficiency and androgen activation before and after puberty. J Clin Endocrinol Metab. 2016; 101(6): 2545– 2553. 27003302 PMC4891801 sourceExperimental — accuracy not yet measured
The paper states in its introductory discussion that severe androgen deficiency had not been reported in STS deficiency. However, its Discussion says earlier studies provided little detailed clinical information, and one prior cohort found mild biochemical androgen deficiency. It therefore supports the absence of reported severe deficiency, but not the stronger implication that several studies assessed and found no clinically significant deficiency. (LLM, conf=0.81)
- Not checked yetcites [78] Ruokonen A, Oikarinen A, Vihko R Regulation of serum testosterone in men with steroid sulfatase deficiency: response to human chorionic gonadotropin. J Steroid Biochem. 1986; 25(1): 113– 119. 3462435 source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“CRD is caused by HSD11B1 deficiency (90) whereas ACRD results form a deficiency in the activity of H6PDH, which is essential for maintaining the reductive activity of HSD11B1 in vivo by the reduced form of NAD phosphate provision to the enzyme (91, 92).”
§ Steroid Metabolome Analysis in Disorders of Adrenal Steroid Biosynthesis and Metabolism > Steroid Metabolome Signatures of Inborn Errors of Steroid Biosynthesis and Metabolism > Inborn disorders of cortisol activation and inactivation
What the sources say
- Not checked yetcites [91] Draper N, Walker EA, Bujalska IJ, Tomlinson JW, Chalder SM, Arlt W, Lavery GG, Bedendo O, Ray DW, Laing I, Malunowicz E, White PC, Hewison M, Mason PJ, Connell JM, Shackleton CH, Stewart PM Mutations in the genes encoding 11β-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency. Nat Genet. 2003; 34(4): 434– 439. 12858176 source
- Supportedcites [92] Lavery GG, Walker EA, Tiganescu A, Ride JP, Shackleton CHL, Tomlinson JW, Connell JM, Ray DW, Biason-Lauber A, Malunowicz EM, Arlt W, Stewart PM Steroid biomarkers and genetic studies reveal inactivating mutations in hexose-6-phosphate dehydrogenase in patients with cortisone reductase deficiency. J Clin Endocrinol Metab. 2008; 93(10): 3827– 3832. 18628520 PMC2579651 source
The paper’s conclusions report that inactivating H6PD mutations cause cortisone reductase deficiency and prevent 11β-HSD1 from functioning as an oxoreductase. Its introductory passage explains that H6PDH supplies the NADPH required for 11β-HSD1 reductase activity in vivo, matching the mechanism attributed to this source. (LLM, conf=0.91)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
88 more claims · 7 with their cited sources checked
Create a free account to see all 213 claims and to verify the 227 references still open.
- It may state two separate claims as one. 109
- Probably not a substantial claim. 22
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In patients with NC CAH, 11-oxo-androgens are elevated about 2-fold compared to women with clinical features of androgen excess, although 11-oxo-androgens alone cannot be used to establish the diagnosis of NC CAH (131).”
From Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management (2022) · cites this paper as [131]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Studies of the steroid profile of patients with congenital adrenal hyperplasia due to deficiencies of 17α-, 11β- or 21-hydroxylase (and POR), corroborate this physiological data, reinforcing the concept of a “MC (or non-17-hydroxylated) pathway of ZF ” ( 3 , 7 - 9 , 18 ).”
From Classic and current concepts in adrenal steroidogenesis: a reappraisal (2022) · cites this paper as [3]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, in 17OHD serum levels of B reach values 100 times higher than normal, in the range of 15 to 50 mcg/dL (normal: 0.1 to 0.6 mcg/dL).”
From Classic and current concepts in adrenal steroidogenesis: a reappraisal (2022) · cites this paper as [3]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although its GC activity is 10 times lower than cortisol, its abundant concentration provides enough GC activity to prevent “addisonian” manifestations in the affected patient ( 3 , 7 , 8 , 20 ).”
From Classic and current concepts in adrenal steroidogenesis: a reappraisal (2022) · cites this paper as [3]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“(i) DOC secretion is amplified by exogenous ACTH stimulation and easily blocked by dexamethasone administration”
From Classic and current concepts in adrenal steroidogenesis: a reappraisal (2022) · cites this paper as [3]
Experimental — accuracy not yet measured
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Steroid Metabolome Analysis in Disorders of Adrenal Steroid Biosynthesis and Metabolism > Steroid Metabolome Signatures of Inborn Errors of Steroid Biosynthesis and Metabolism > Inborn disorders of androgen biosynthesis and metabolism
“In contrast to 17,20-lyase deficiency in the context of CYP17A1 deficiency (see “CAH due to CYP21A2 deficiency” above)”
§ Steroid Metabolome Analysis in Disorders of Adrenal Steroid Biosynthesis and Metabolism > Steroid Metabolome Signatures of Inborn Errors of Steroid Biosynthesis and Metabolism > The steroid metabolome in congenital adrenal hyperplasia
“#### CAH due to CYP17A1 deficiency”
Citations
Cites
Funder, J. W., Carey, R. M., Mantero, F., Murad, M. H., Reincke, M., Shibata, H., Stowasser, M., & Young, W. F. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-4061 · Cited by 2,925
The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.
Nieman, L. K., Biller, B. M. K., Findling, J. W., Newell-Price, J., Savage, M. O., Stewart, P. M., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0125 · Cited by 2,718
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
Miller, W. L., & Auchus, R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0013 · Cited by 2,458
Arriza, J. L., Weinberger, C., Cerelli, G., Glaser, T. M., Handelin, B. L., Housman, D. E., & Evans, R. M. (1987) · Science · doi:10.1126/science.3037703 · Cited by 1,946
Lacroix, A., Feelders, R. A., Stratakis, C. A., & Nieman, L. K. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61375-1 · Cited by 1,777
Fassnacht, M., Arlt, W., Bancos, I., Dralle, H., Newell-Price, J., Sahdev, A., Tabarin, A., Terzolo, M., Tsagarakis, S., & Dekkers, O. M. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0467 · Cited by 1,566
Self-citationEvidence for an increased rate of cardiovascular events in patients with primary aldosteronism
Milliez, P., Girerd, X., Plouin, P.-F., Blacher, J., Safar, M. E., & Mourad, J.-J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.01.015 · Cited by 1,547
Lifton, R. P., Dluhy, R. G., Powers, M., Rich, G. M., Cook, S., Ulick, S., & Lalouel, J.-M. (1992) · Nature · doi:10.1038/355262a0 · Cited by 1,158
K + Channel Mutations in Adrenal Aldosterone-Producing Adenomas and Hereditary Hypertension
Choi, M., Scholl, U. I., Yue, P., Björklund, P., Zhao, B., Nelson-Williams, C., Ji, W., Cho, Y., Patel, A., Men, C. J., et al. (2011) · Science · doi:10.1126/science.1198785 · Cited by 1,004
Else, T., Kim, A. C., Sabolch, A., Raymond, V. M., Kandathil, A., Caoili, E. M., Jolly, S., Miller, B. S., Giordano, T. J., & Hammer, G. D. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1029 · Cited by 892
Cited by
Small molecule metabolites: discovery of biomarkers and therapeutic targets
Qiu, S., Cai, Y., Yao, H., Lin, C., Xie, Y., Tang, S., & Zhang, A. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01399-3 · Cited by 884
Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management
Claahsen - van der Grinten, H. L., Speiser, P. W., Ahmed, S. F., Arlt, W., Auchus, R. J., Falhammar, H., Flück, C. E., Guasti, L., Huebner, A., Kortmann, B. B. M., et al. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab016 · Cited by 556
Self-citationSherlock, M., Scarsbrook, A., Abbas, A., Fraser, S., Limumpornpetch, P., Dineen, R., & Stewart, P. M. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa008 · Cited by 347
“This has been extensively reviewed by Storbeck et al. (344).”
Congenital adrenal hyperplasia
Auer, M. K., Nordenström, A., Lajic, S., & Reisch, N. (2023) · The Lancet · doi:10.1016/s0140-6736(22)01330-7 · Cited by 215
The Biosynthesis of Enzymatically Oxidized Lipids
Hajeyah, A. A., Griffiths, W. J., Wang, Y., Finch, A. J., & O’Donnell, V. B. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.591819 · Cited by 180
Normal and Premature Adrenarche
Rosenfield, R. L. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnab009 · Cited by 187
“(C) Normal androgen and glucocorticoid suppression is found in atypical premature adrenarche and in cortisol reductase deficiency or apparent CRD.”
BackgroundInfluentialRare and common genetic determinants of metabolic individuality and their effects on human health
Surendran, P., Stewart, I. D., Auyeung, V. P. W., Pietzner, M., Raffler, J., Wörheide, M. A., Li, C., Smith, R. F., Wittemans, L. B. L., Bomba, L., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-02046-0 · Cited by 166
Self-citationJing, Y., Hu, J., Luo, R., Mao, Y. J., Luo, Z., Zhang, M., Yang, J., Song, Y., Feng, Z., Wang, Z., et al. (2022) · Annals of Internal Medicine · doi:10.7326/m22-1619 · Cited by 157
Eisenhofer, G., Durán, C., Cannistraci, C. V., Peitzsch, M., Williams, T. A., Riester, A., Burrello, J., Buffolo, F., Prejbisz, A., Beuschlein, F., et al. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.16209 · Cited by 131
Management challenges and therapeutic advances in congenital adrenal hyperplasia
Mallappa, A., & Merke, D. P. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00655-w · Cited by 113
Modified-Release Hydrocortisone in Congenital Adrenal Hyperplasia
Merke, D. P., Mallappa, A., Arlt, W., Brac de la Perriere, A., Lindén Hirschberg, A., Juul, A., Newell-Price, J., Perry, C. G., Prete, A., Rees, D. A., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab051 · Cited by 109
“Age, y, median (range) 35 (19-61) 40 (19-68) 35 (20-67)”
BackgroundSelf-citationHigh-resolution daily profiles of tissue adrenal steroids by portable automated collection
Upton, T. J., Zavala, E., Methlie, P., Kämpe, O., Tsagarakis, S., Øksnes, M., Bensing, S., Vassiliadi, D. A., Grytaas, M. A., Botusan, I. R., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.adg8464 · Cited by 94
“Likewise, although a detailed examination of urine collections provides insights into overall changes in steroid production and metabolism (23), urine is necessarily an integrated measure and cannot provide finegrained detail about dynamic features, especially if the collection sample covers a full day.”
BackgroundBertherat, J. Y., Bourdeau, I., Bouys, L., Chasseloup, F., Kamenický, P., & Lacroix, A. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac034 · Cited by 100
From a single steroid to the steroidome: Trends and analytical challenges
Olesti, E., Boccard, J., Visconti, G., González-Ruiz, V., & Rudaz, S. (2021) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2020.105797 · Cited by 74
Witchel, S. F., Pinto, B., Burghard, A. C., & Oberfield, S. E. (2020) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000928 · Cited by 79
The clinical and biochemical significance of 11-oxygenated androgens in human health and disease
Storbeck, K.-H., & O’Reilly, M. W. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad047 · Cited by 63
Self-citationClinical and Technical Aspects in Free Cortisol Measurement
Choi, M. H. (2022) · Endocrinology and Metabolism · doi:10.3803/enm.2022.1549 · Cited by 73
“Moreover, exogenous corticosteroids can be assessed simultaneously with target endogenous adrenal steroids [74,77], which can provide new insights into the pathophysiology of adrenal steroidogenesis [78].”
BackgroundMulti-steroid profiling by UHPLC-MS/MS with post-column infusion of ammonium fluoride
Schiffer, L., Shaheen, F., Gilligan, L. C., Storbeck, K.-H., Hawley, J. M., Keevil, B. G., Arlt, W., & Taylor, A. E. (2022) · Journal of Chromatography B · doi:10.1016/j.jchromb.2022.123413 · Cited by 52
Self-citationTreating Primary Aldosteronism-Induced Hypertension: Novel Approaches and Future Outlooks
Mullen, N., Curneen, J. M. G., Donlon, P. T., Prakash, P., Bancos, I., Gurnell, M., & Dennedy, M. C. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad026 · Cited by 56
Clinical advances in the pharmacotherapy of congenital adrenal hyperplasia
Prete, A., Auchus, R. J., & Ross, R. J. (2022) · White Rose Research Online (University of Leeds, The University of Sheffield, University of York) · Cited by 46
Self-citationAbnormal body composition in patients with adrenal adenomas
Delivanis, D. A., Hurtado Andrade, M. D., Cortes, T., Athimulam, S., Khanna, A., Atkinson, E., McKenzie, T., Takahashi, N., Moynagh, M. R., & Bancos, I. (2021) · European Journal of Endocrinology · doi:10.1530/eje-21-0458 · Cited by 43
Classic and current concepts in adrenal steroidogenesis: a reappraisal
Kater, C. E., Giorgi, R. B., & Costa-Barbosa, F. A. (2022) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000438 · Cited by 43
“…towards the RAS do not alter its production: volume expansion by saline infusion, high-sodium diet and fludrocortisone do not reduce DOC levels, whereas postural stimulation, diuretics, low-sodium diet, and angiotensin III infusion do not substantially increase its concentration (3,7,8,17,18).”
InfluentialCastro, M. A., Valderrábano, P., Escobar-Morreale, H. F., Hanzu, F. A., & Casals, G. (2020) · Endocrine · doi:10.1007/s12020-020-02544-6 · Cited by 36
Laugesen, K., Broersen, L. H. A., Hansen, S. B., Dekkers, O. M., Sørensen, H. T., & Jorgensen, J. O. L. (2021) · European Journal of Endocrinology · doi:10.1530/eje-20-1199 · Cited by 32
Steroid profiling in the diagnosis of mild and overt Cushing’s syndrome
Athimulam, S., Grebe, S. K. G., & Bancos, I. (2021) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2021.101488 · Cited by 34
“Steroids can undergo metabolism in the liver, or can be directly excretes in the urine(47, 48).”
BackgroundPozo, O. J., Marcos, J., Khymenets, O., Pranata, A., Fitzgerald, C. C., McLeod, M. D., & Shackleton, C. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-17-0286 · Cited by 30
Self-citationThe broad phenotypic spectrum of 17α-hydroxylase/17,20-lyase (CYP17A1) deficiency: a case series
Sun, M., Mueller, J. W., Gilligan, L. C., TAYLOR, A. E. R., Shaheen, F., Noczyńska, A., T'Sjoen, G. G., Denvir, L., Shenoy, S., Fulton, P., et al. (2021) · European Journal of Endocrinology · doi:10.1530/eje-21-0152 · Cited by 31
“Urinary steroid profiling by mass spectrometry represents a powerful diagnostic tool not only in establishing the diagnosis but also in predicting the severity of the phenotype (38).”
Self-citationAn integrated single-cell analysis of human adrenal cortex development
del Valle, I., Young, M. D., Kildisiute, G., Ogunbiyi, O. K., Buonocore, F., Simcock, I. C., Khabirova, E., Crespo, B., Moreno, N., Brooks, T., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.168177 · Cited by 36
Steroid profiling of glucocorticoids in microdissected mouse brain across development
Hamden, J. E., Gray, K. M., Salehzadeh, M., Kachkovski, G. V., Forys, B. J., Ma, C., Austin, S. H., & Soma, K. K. (2021) · Developmental Neurobiology · doi:10.1002/dneu.22808 · Cited by 33
“The measurement of active GCs as well as their precursors and metabolites provides greater insight into the systemic and local steroid environments, and the large dataset permits additional statistical approaches as described below (Lattin et al., 2015; Storbeck et al., 2019).”
BackgroundClassic and backdoor pathways of androgen biosynthesis in human sexual development
Lee, H. G., & Kim, C. J. (2022) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2244124.062 · Cited by 42
Alyamani, M., Li, J., Patel, M., Taylor, S., Nakamura, F., Berk, M. P., Przybycin, C. G., Posadas, E. M., Madan, R. A., Gulley, J. L., et al. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2019.12.002 · Cited by 28
Barnard, L., Nikolaou, N., Louw, C., Schiffer, L., Gibson, H., Gilligan, L. C., Gangitano, E., Snoep, J., Arlt, W., Tomlinson, J. W., et al. (2020) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2020.105724 · Cited by 25
“Our data also shows that a proportion of 11KT metabolism would yield 11KAn, which is currently not routinely included in GC–MS urine analyses [19,54].”
BackgroundSelf-citationLong‐term health consequences of congenital adrenal hyperplasia
Pofi, R., Ji, X., Krone, N. P., & Tomlinson, J. (2023) · Clinical Endocrinology · doi:10.1111/cen.14967 · Cited by 30
“Historically, studies had shown male patients with classic CAH to be less likely to father children, however, with early diagnosis of classic CAH, fertility may be normalised.”
InfluentialPlant Metabolomics: The Future of Anticancer Drug Discovery
Dabbousy, R., Rima, M., Roufayel, R., Rahal, M. K., Legros, C., Sabatier, J., & Fajloun, Z. (2024) · Pharmaceuticals · doi:10.3390/ph17101307 · Cited by 24
“Metabolomics is the inclusive study of all the metabolites found in a biological system, including carbohydrates, amino acids, lipids, organic acids [25], aldehydes [26], steroids [27], vitamins [28], polyphenols [29], hormones, and signaling molecules [30].”
BackgroundNowotny, H. F., Auer, M. K., Lottspeich, C., Schmidt, H., Dubinski, I., Bidlingmaier, M., Adaway, J., Hawley, J., Keevil, B., & Reisch, N. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab446 · Cited by 22
Altinkilic, E. M., du Toit, T., Sakin, Ö., Attar, R., Groessl, M., & Flück, C. E. (2023) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2023.106366 · Cited by 22
“Recently, the biochemistry behind human androgen biosynthesis has risen as a hot topic in PCOS research, due to newer chromatographic and mass spectrometric methods [30,39,52], novel pathways and active androgen metabolites which have been (re-)discovered in diseases and disorders [47,58].”
BackgroundSteroid profile analysis by LC-HRMS in human seminal fluid
Olesti, E., Garcia, A., Rahban, R., Rossier, M. F., Boccard, J., Nef, S., González‐Ruiz, V., & Rudaz, S. L. (2019) · Journal of Chromatography B · doi:10.1016/j.jchromb.2019.121929 · Cited by 22
Delineating endogenous Cushing’s syndrome by GC-MS urinary steroid metabotyping
Braun, L., Oßwald, A., Zopp, S., Rubinstein, G., Vogel, F., Riester, A., Honegger, J. B., Eisenhofer, G., Constantinescu, G. A., Deutschbein, T., et al. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104907 · Cited by 21
“11,12 GC-MS urinary steroid metab-otyping has gained further importance since it has proven highly valuable in monitoring treatment of children with congenital adrenal hyperplasia 13 or primary adrenal insuf fi ciency.”
BackgroundSaini, J., Singh, S., Ebbehoj, A., Zhang, C. D., Nathani, R., Fell, V., Atkinson, E., Achenbach, S., Rivard, A., Singh, R., et al. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae468 · Cited by 20
Steroid Sulfation in Adrenal Tumors
Mueller, J. W., Vogg, N., Lightning, T. A., Weigand, I., Ronchi, C. L., Foster, P., & Kroiß, M. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab182 · Cited by 24
Briegel, J., Möhnle, P., Keh, D., Lindner, J. M., Vetter, A. C., Bogatsch, H., Lange, D., Frank, S., Hinske, L. C., Annane, D., et al. (2022) · Critical Care · doi:10.1186/s13054-022-04224-5 · Cited by 20
“1), which catalyzes the conversion of 11-desoxycorticosterone into corticosterone, is localized on the inner mitochondrial membrane [20, 21].”
BackgroundRamos, L., Vilchis, F., Chávez, B. A., & Mares, L. (2020) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2020.105691 · Cited by 16
11-Keto-testosterone and Other Androgens of Adrenal Origin
Stárka, L., Dušková, M., & Vítků, J. (2020) · Physiological Research · doi:10.33549/physiolres.934516 · Cited by 16
Serum cortisol assay performance following the 1 mg overnight dexamethasone suppression test
Atkins, J. S., Hawley, J. M., Owen, L. J., Clayton, J. C., Scargill, J., & Keevil, B. G. (2023) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/00045632231179560 · Cited by 16
“19,29,42 Negative bias may be introduced by pregnancy and oral contraceptive pill use.”
BackgroundNoh, J., Lee, C., Kim, J. H., Myung, S. W., & Choi, M. H. (2023) · Journal of Lipid Research · doi:10.1016/j.jlr.2023.100453 · Cited by 18
“The established method reflects the clinical signatures of individual adrenal tumors of CS (5, 13, 22, 23), PA (5, 13,1 4)), and PPGL (11, 12, 14) characterized by excessive secretion of glucocorticoids, mineralocorticoids, and catecholamines, respectively.”
MethodSerum Steroid Profiling in the Diagnosis of Adrenocortical Carcinoma: A Prospective Cohort Study
Yu, K., Athimulam, S., Saini, J., Kaur, R. J., Xue, Q., McKenzie, T. J., Singh, R. J., Grebe, S. K. G., & Bancos, I. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae604 · Cited by 16
Persistent cardiac organ damage in surgically and medically treated primary aldosteronism
Aune, A., Gerdts, E., Kokorina, M., Kringeland, E. A., Midtbø, H. B., Løvås, K., & Grytaas, M. A. (2022) · Journal of Hypertension · doi:10.1097/hjh.0000000000003135 · Cited by 13
Casals, G., Vizoso, M. A. B., Zamora, A., Martínez, I., Fernández‐Varo, G., Mora, M., Hanzu, F. A., & Morales‐Ruiz, M. (2024) · Biomolecules · doi:10.3390/biom14050558 · Cited by 15
“…role of urine cortisol measurements in CS, the cortisol/cortisone ratio (11 β -hydroxysteroid dehydrogenase 2 (11 β HSD2) activity) is a sensitive marker for the apparent mineralocorticoid excess syndrome [10] and may help to differentiate between Cushing’s disease and ectopic ACTH production [11].”
BackgroundMethodIannone, M., Dima, A. P., Sciarra, F., Botrè, F., & Isidori, A. M. (2022) · Biomedical Chromatography · doi:10.1002/bmc.5344 · Cited by 15
Dineen, R., Martin‐Grace, J., Ahmed, K. M. S., TAYLOR, A. E. R., Shaheen, F., Schiffer, L., Gilligan, L. C., Lavery, G. G., Frizelle, I. M., Gunness, A., et al. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad370 · Cited by 14
Self-citationCortisol: Analytical and clinical determinants
Vega‐Beyhart, A., Castro, M. A., Hanzu, F. A., & Casals, G. (2022) · Advances in clinical chemistry · doi:10.1016/bs.acc.2022.11.005 · Cited by 14
Interpretable modelling and visualization of biomedical data
Ghosh, S., Baranowski, E. S., Biehl, M. L., Arlt, W., Tiňo, P., & Bunte, K. (2025) · Neurocomputing · doi:10.1016/j.neucom.2025.129405 · Cited by 17
“It has been proposed that using ratios of metabolites reduces some of this heterogeneity, allowing direct comparison of results obtained from different urine collection methods (Arlt et al., 2004; Storbeck et al., 2019; Baranowski et al., 2018).”
Self-citationDong, H., Hu, B., Chen, W., Wang, L., Sun, H., Zhou, J., Chen, B., Chen, B., & Du, Z. (2024) · Journal of Chromatography B · doi:10.1016/j.jchromb.2024.124012 · Cited by 10
Gazárková, T., Vlčková, H., Plachká, K., Vagnerová, K., Dubecová, D., Klusoňová, P., Pácha, J., Švec, F., & Nováková, L. (2024) · Analytica Chimica Acta · doi:10.1016/j.aca.2024.343362 · Cited by 11
Approach to patients with bilateral adrenal incidentalomas
Vassiliadi, D. A., Partsalaki, E., & Tsagarakis, S. (2020) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000536 · Cited by 12
Cortisol in metabolic syndrome
Mazgelytė, E., & Karčiauskaitė, D. (2024) · Advances in clinical chemistry · doi:10.1016/bs.acc.2024.06.008 · Cited by 24
Dow, C. T., & Kidess, Z. (2025) · Journal of Clinical Anesthesia · doi:10.1016/j.jclinane.2024.111736 · Cited by 10
Rare forms of genetic steroidogenic defects affecting the gonads and adrenals
Boettcher, C., & Flück, C. E. (2021) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2021.101593 · Cited by 12
Liu, Q., Yin, X., & Li, P. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.06.002 · Cited by 11
Osorio-Méndez, D., Miller, A. H., Begeman, I. J., Kurth, A., Hagle, R., Rolph, D., Dickson, A. L., Chen, C., Halloran, M. C., Poss, K. D., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2200342119 · Cited by 9
“npas4a and fosab (38, 39), circadian clock genes (nr1d1, nocta, and ciarta) (40–42), and steroid biosynthesis genes (hsd11b2, cyp51, and srd5a2b) (43).”
BackgroundLane, T. R., Vignaux, P. A., Harris, J. S., Snyder, S. H., Urbina, F., & Ekins, S. (2025) · Environmental Science & Technology · doi:10.1021/acs.est.5c04054 · Cited by 10
Yang, M., Ji, Y., Yong, T., Liu, T., Yang, S., Guo, S., Meng, F., Han, X., Liang, Q., Cao, X., et al. (2022) · Poultry Science · doi:10.1016/j.psj.2022.102379 · Cited by 9
“served among vertebrate species, which involves a canonical StAR-P450scc enzymatic cascade using cholesterol as substrate (Storbeck et al., 2019).”
BackgroundLi, Y., Qin, Y., Wei, S., Ling, L., & Ding, C. (2023) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-023-05019-5 · Cited by 7
“Steroids participate in the regulation of various physiological processes and reproductive development throughout the lifetime [2–4].”
Etika, S. B., & Iryani, I. (2019) · EKSAKTA Berkala Ilmiah Bidang MIPA · doi:10.24036/eksakta/vol20-iss2/186 · Cited by 9
“27 cm (1,300-900 cm) which is a strain vibration of C-O alcohol, this confirms that the isolated flavonoids have a hydroxy (OH) functional group [14].”
BackgroundSnaterse, G., van Dessel, L. F., TAYLOR, A. E. R., Visser, J. A., Arlt, W., Lolkema, M. P., & Hofland, J. (2021) · Steroids · doi:10.1016/j.steroids.2021.108800 · Cited by 10
Self-citationNMR-based metabolic profiling of children with premature adrenarche
Matzarapi, K., Giannakopoulos, A., Chasapi, S. A., Kritikou, D., Efthymiadou, A., Chrysis, D., & Spyroulias, G. A. (2022) · Metabolomics · doi:10.1007/s11306-022-01941-4 · Cited by 7
“Considering that children with PA have their own steroid metabolic pattern (Remer et al., 2005; Storbeck et al., 2019), we examined a standard group of steroid hormones which are commonly used in clinical practice as markers of their PA clinical characteristics.”
MethodHonour, J. W. (2024) · Steroids · doi:10.1016/j.steroids.2024.109502 · Cited by 7
Modelling adrenal steroid profiles to inform monitoring guidance in congenital adrenal hyperplasia
Lawrence, N., Dawson, J., Lang, Z., Prete, A., Baranowski, E. S., Schiffer, L., TAYLOR, A. E. R., de la Perrière, A. B., Hirschberg, A. L., Juul, A., et al. (2025) · EBioMedicine · doi:10.1016/j.ebiom.2025.105749 · Cited by 8
Self-citationPremature adrenarche and metabolic risk: a systematic review and meta-analysis
Said, W. B., Lempesis, I. G., Fernandez-Garcia, S., Thangaratinam, S., Arlt, W., & Idkowiak, J. (2025) · European Journal of Endocrinology · doi:10.1093/ejendo/lvaf167 · Cited by 6
“1,2 Recent work has highlighted that adre-nally derived 11-oxygenated androgens, a long-time known, previously neglected but re-discovered androgen class due to their high androgenic capability, 76,77 are the predominant circulating androgens in (premature) adrenarche.”
Self-citationThe Multienzyme Complex Nature of Dehydroepiandrosterone Sulfate Biosynthesis
Tumilovich, A. A., Yablokov, E. O., Mezentsev, Y. V., Ershov, P., Basina, V. P., Gnedenko, O. V., Kaluzhskiy, L. A., Tsybruk, T. V., Grabovec, I. P., Kisel, M., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042072 · Cited by 8
Alteration in glucocorticoids secretion and metabolism in patients affected by cystic fibrosis
Podgórski, R., Sumińska, M., Rachel, M., Fichna, M., Fichna, P., & Mazur, A. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1074209 · Cited by 7
Li, Y., Wang, T., Qin, S., Li, Y., Hu, W., & Cheng, W. (2023) · Chromatographia · doi:10.1007/s10337-023-04244-5 · Cited by 6
Yarmolinskaya, M. I., Glavnova, O. B., Ворохобина, Н. В., Великанова, Л. И., & Валерьевна, М. Е. (2024) · Minerva Obstetrics and Gynecology · doi:10.23736/s2724-606x.24.05461-7 · Cited by 6
Glavnova, O. B., Ворохобина, Н. В., Великанова, Л. И., Yarmolinskaya, M. I., Валерьевна, М. Е., Геннадьевна, С. Е., & Александровна, Б. К. (2022) · Medical Herald of the South of Russia · doi:10.21886/2219-8075-2022-13-3-107-117 · Cited by 4
Assessment of steroid enzymes action in children and adolescents with obesity
Sumińska, M., Podgórski, R., Fichna, P., Mazur, A., & Fichna, M. (2023) · Steroids · doi:10.1016/j.steroids.2023.109325 · Cited by 4
The association of infant urinary adrenal steroids with the risk of childhood asthma development
Turi, K. N., Li, Y., Xu, Y., Gebretsadik, T. S., Rosas‐Salazar, C., Wiggins, D. A., McKennan, C. G., Newcomb, D. C., Gern, J. E., & Hartert, T. V. (2024) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2024.04.008 · Cited by 5
Baranowski, E. S., Idkowiak, J., Waterson, J. R., DʼHarlingue, A. E., Olney, A. H., Ivison, H., Hughes, B., Mueller, J., Arlt, W., & Shackleton, C. H. L. (2025) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2025.106760 · Cited by 4
“Later studies confirmed this altered metabolome, which was finally defined as the inactivation of POR [3,11 – 14].”
InfluentialSelf-citationSaptarini, N. M., Mustarichie, R., Herawati, I. E., & Hadisoebroto, G. (2022) · International Journal of Applied Pharmaceutics · doi:10.22159/ijap.2022.v14s4.pp19 · Cited by 3
Effects of Methyl Farnesoate on the Growth and Antioxidant Capacity of Neocaridina denticulata
Chen, Y., Sun, X., Du, J., Hu, J., Bao, Z., & Qu, Z. (2025) · Antioxidants · doi:10.3390/antiox14060635 · Cited by 4
Yang, X., Zhang, T., Shang, J., Xue, Q., Kuai, Y., Wang, S., & Xu, Y. Y. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.971993 · Cited by 3
“Low cortisol levels in 17OHD lead to ACTH hypersecretion and in absence of P450c17, its substrates (deoxycorticosterone, 18-deoxycorticosterone, and progesterone) accumulate, with concomitant product (cortisol, androgen, and oestrogen) reduction (2).”
BackgroundChanges of androgen and corticosterone metabolites excretion and conversion in cystic fibrosis
Podgórski, R., Sumińska, M., Rachel, M., Pikuła, B., Fichna, P., Bidlingmaier, M., & Fichna, M. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1244127 · Cited by 3
Hepatic metabolism of 11-oxygenated androgens in humans: an integrated in vivo and ex vivo approach
McDonnell, T., Anthony, A., Clarke, G., Schiffer, L., TAYLOR, A. E. R., Cussen, L., Fan, Y., Hann, A., Mao, J., Shaheen, F., et al. (2025) · European Journal of Endocrinology · doi:10.1093/ejendo/lvaf166 · Cited by 4
“11 The liver is the primary site of steroid metabolism prior to urinary excretion.”
Self-citationThe importance of mass spectrometry in unravelling steroid action in breast cancer
Storbeck, K., & McNamara, K. M. (2020) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2020.11.007 · Cited by 3
Self-citationChiara, F., Allegra, S., Liuzzi, S., Puccinelli, M. P., Mengozzi, G., & Francia, S. D. (2025) · Life · doi:10.3390/life15060829 · Cited by 5
“The final profile, detailed in Tables 1–5 was selected to maximize clinical relevance based on both the legacy literature and recent metabolomic evidence [13].”
Yamano, H., Watanabe, K., Komatsu, M., Hashimoto, A., Suzuki, Y. Y., Kirino, S., Saito, Y., Adachi, E., Gau, M., Nakatani, H., et al. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf506 · Cited by 2
Liu, Y., Cai, S., Zhang, T., Kong, X., Zhou, J., Chen, B., & Li, Z. (2025) · Clinica Chimica Acta · doi:10.1016/j.cca.2025.120700 · Cited by 2
North, E., Gessner, A., Kurlbaum, M., Faßnacht, M., Kroiß, M., Fromm, M. F., & Bartels, N. (2025) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2025.117258 · Cited by 2
Long, K. C., & Azizan, E. A. B. A. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1736534 · Cited by 3
Odermatt, A., & Morris, D. J. (2026) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2026.106954 · Cited by 2
Watson, A. H., Gilligan, L. C., TAYLOR, A. E. R., Arlt, W., & Syme, H. M. (2025) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.70209 · Cited by 3
“Targeted steroid metabolome analysis in humans has identified signature steroid profiles associated with disorders of steroid biosynthesis and metabolism, and provided insights into the pathophysiology of adrenal disease [7].”
Self-citationCarranza, J., Yamada, K., Sakae, Y., Noh, J., Choi, M. H., & Tanaka, M. (2024) · ZOOLOGICAL SCIENCE · doi:10.2108/zs230107 · Cited by 2
“…such as 17 α -hydroxyprogesterone, allows us to speculate that there is high androgen production in medaka mutants, like in the case of human 21OHD (Reisch et al., 2019; Storbeck et al., 2019), which could potentially cause sex reversal of medaka secondary sex characteristics from female to male.”
BackgroundInterpretable Machine Learning in Endocrinology: A Diagnostic Tool in Primary Aldosteronism
Biehl, M. L., Pavlov, D., Sitch, A. J., Prete, A., & Arlt, W. (2024) · Lecture notes in networks and systems · doi:10.1007/978-3-031-67159-3_11 · Cited by 2
Self-citationMetabolomics and Genomics in Endocrinology
Bandarian, F., Dehghanbanadaki, H., Khashayar, P., Rezaei–Tavirani, M., Amoli, M. M., Panahi, N., Bandarian, M., & Razi, F. (2025) · Springer eBooks · doi:10.1007/978-981-95-2286-6_7 · Cited by 1
Rubio, A., Tofé, S., & Antonia, B. (2026) · Clinica Chimica Acta · doi:10.1016/j.cca.2026.120909 · Cited by 1
Zhang, Z., Chen, C., Zhang, M., Zhu, J., Xu, X., Wang, Z., Zhou, L., Wu, C., Zong, M., Yin, T., et al. (2026) · Gut Microbes · doi:10.1080/19490976.2026.2657047 · Cited by 1
“Given that aldosterone is known to undergo reductive metabolism in humans to form biologically inactive metabolites such as 3α,5β-tetrahydroaldosterone, 36,37 we further examined whether this metabolite could be detected in the supernatant of R. gnavus cultures incubated with aldosterone.”
Honour, J. W. (2026) · RSC Advances · doi:10.1039/d5ra08275g · Cited by 1
“55 Diagnostic conventions o en rely on shorthand labels, for example CAH, that must be interpreted within a clinical context.”
Houang, M., Nguyen‐Khoa, T., Eguether, T., Ribault, B., Brabant, S., Polak, M., Netchine, I., & Lamazière, A. (2022) · Endocrine Connections · doi:10.1530/ec-22-0101 · Cited by 6
Breakdown and clearance of steroids
Honour, J. W. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-818124-9.00001-2 · Cited by 2
Темердашев, А. З., Zorina, M., Feng, Y., Gashimova, E. M., Dotsenko, V. V., Ioutsi, V., & Atapattu, S. N. (2024) · Molecules · doi:10.3390/molecules29112433 · Cited by 1
“Previously published studies have demonstrated the diagnostic significance of determining conjugated forms, which can serve as distinct indicators for the presence of anabolic steroids or play a crucial role in diagnosing various diseases [8–12].”
BackgroundThe role of steroidogenesis disorders in developing congenital clitoromegaly
Ivanov, N. V., Павловна, С. И., Radugina, L. I., Михайлович, Р. Ф., & Yusupova, S. K. (2024) · Obstetrics Gynecology and Reproduction · doi:10.17749/2313-7347/ob.gyn.rep.2024.494 · Cited by 1
Metadata
- Authors
- Storbeck, K.-H., Schiffer, L., Baranowski, E. S., Chortis, V., Prete, A., Barnard, L., Gilligan, L. C., Taylor, A. E., Idkowiak, J., Arlt, W., & Shackleton, C. H. L.
- Affiliations
- Stellenbosch University (ZA)
- University of Birmingham (GB)
- Birmingham Women’s and Children’s NHS Foundation Trust (GB)
- University Hospitals Birmingham NHS Foundation Trust (GB)
- University of California, San Francisco (US)
- Corresponding author
- Arlt, Wiebke
- ORCID
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2019-07-11
- Volume
- 40
- Issue
- 6
- Pages
- 1605-1625
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- PMC
- PMC6858476
- OpenAlex
- W2960176468
- Semantic Scholar
- 807dd6287c13d38cf71f318250f2bb11b80bb36b
- Cited by
- 141
- References
- 206
- Citations by year
- 2026: 16 · 2025: 22 · 2024: 21 · 2023: 25 · 2022: 26 · 2021: 13 · 2020: 14 · 2019: 3
- FWCI
- 11.36
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Endocrine Reviews (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion, cc-by)
- SUNScholar (Stellenbosch University) (submittedVersion)
- Spiral (Imperial College London) (submittedVersion, cc-by)
- Funders
- Wellcome Trust (WT209492/Z/17/Z, WT101671AIA)
- Medical Research Council (G1001964, MR/R017913/1)
- Diabetes UK (18/0005782)
- Academy of Medical Sciences UK (NAF004\1002)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Keywords
- steroid metabolome, adrenal steroidogenesis, serum steroids, adrenal tumors, personalized diagnosis, differential diagnosis, outcome prediction, machine learning
- MeSH terms
- Adrenal Gland Diseases, Diagnosis, Differential, Humans, Steroid Metabolism, Inborn Errors, Metabolome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.